Mona Haj, MD

Dr. Mona Haj earned her Bachelor of Science in biology from the University of Michigan in Dearborn in 2011. She received her medical degree from the American University of Beirut in Lebanon in 2015 and completed her Categorical Medicine residency in 2021 in the Department of Gastroenterology and Hepatology at Medical University of South Carolina in Charleston.

Dr. Haj is a member of the American Association for the Study of Liver Diseases and the American Gastroenterological Association.

Dr. Haj enjoys high-intensity interval training, Vinyasa yoga, knitting, crossword puzzles, and baking.

Oral Presentations

• Haj M, El Hajj M, Rockey DC. (April 2019). Does Ischemic Hepatitis Cause Acute Liver Failure? Oral Presentation at: MUSC Department of Medicine – Grand Rounds Charleston, SC, USA
• Haj M, El Hajj M, Rockey DC. (May 2019). Ischemic Hepatitis Does Not Cause Acute Liver Failure Oral Presentation at: Digestive Disease Week 2019 San Francisco, CA, USA
• Haj M, Rockey DC. (September 2019). Clinical Cases in Gastroenterology and Hepatology Oral Presentation at: Sixth Annual Update in Gastroenterology and Hepatology Charleston, SC, USA
• Haj M. (October 2019). Rifaximin for Hepatic Encephalopathy Oral Presentation at: Salix Pharmaceuticals – Rifaximin Clinical Trial Panel Discussions Dallas, TX, USA
• Haj M, Rockey DC. (October 2019). Management of Hepatic Encephalopathy Oral Presentation at: MUSC Division of Gastroenterology & Hepatology – New Nurses Training Charleston, SC, USA

Peer-Reviewed Manuscripts

• Haj M, Hart M, Rockey DC. Development of a novel clinical staging model using the Nationwide Inpatient Sample. J Investig Med. 2018;66(6):992-997.
• Haj M, Haj M, Rockey DC. Ogilvie’s syndrome: management and outcomes. Medicine. 2018;97(27).
• Haj M, Rockey DC. Predictors of clinical outcomes in cirrhosis patients. Current Opinion in Gastroenterology. 2018;34(4):266-271.
• Haj M, Douglas K, Rockey DC. Albumin administration is ineffective for the treatment of acute kidney injury in patients with cirrhosis. Ann Intern Med. Submitted
• Haj M, Rockey DC. Ammonia levels do not guide clinical management in patients with hepatic encephalopathy caused by cirrhosis. Am J Gastroenterol. 2019. Published ahead of print.
• El Hajj MC, Fleming J, Haj M et al. Heart failure with preserved ejection fraction is common and does not predict outcomes in liver transplant recipients. JACC. 2020;75(11)

Published Abstracts

• Haj M, Bickford M, Forster E. Race influences clinical outcomes of patients with primary sclerosing cholangitis and inflammatory bowel disease [Sa1834]. Gastroenterology. 2020, Apr; 158(6):S444-S445.
• Haj M, Rockey DC. NASH cirrhosis is associated with increased inpatient mortality [Mo1487]. Gastroenterology. 2020, Apr, 158(6):S-1422

National Conference Presentations

• Haj M, Hart M, Rockey DC. Development of a novel staging model for cirrhosis outcomes using the Nationwide Inpatient Sample. (Poster) Presented at: The Liver Meeting 2016, Boston, MA, USA
• Haj M, Rockey DC. Ammonia levels are not related to lactulose dose in patients with acute hepatic encephalopathy. (Poster) Presented at: Digestive Disease Week (DDW) 2017, Chicago, IL, USA
• Haj M, Haj M, Rockey DC. Current management of Ogilvie’s Syndrome. Presented at: Digestive Disease Week (DDW) 2017, Chicago, IL, USA
• Haj M, Rockey DC. Lactulose-induced hypernatremia in patients with hepatic encephalopathy. (Poster) Presented at: The Liver Meeting (2017), Washington DC
• Haj M, Totin L, Rockey DC. Rectal versus oral lactulose in patients admitted with hepatic encephalopathy. (Poster) Presented at: The Liver Meeting (2017), Washington DC, USA
• Haj M, Bickford M, Forster E. Race influences clinical outcomes of patients with primary sclerosing cholangitis and inflammatory bowel disease. (ePoster). Digestive Disease Week (DDW) 2020 [virtual conference]
• Haj M, Rockey DC. NASH cirrhosis is associated with increased inpatient mortality. (ePoster). Digestive Disease Week (DDW) 2020 [virtual conference]
• Haj M, Sweetnam V, Willner I. Hemolytic anemia and renal failure as extrahepatic manifestations of acute Hepatitis A. (ePoster). National Meeting of the Society of General Internal Medicine, 2020.

Research

• Haj M & Rockey DC. A risk scoring system to predict cirrhosis mortality in the hospital and ICU
• Haj M & Rockey DC. Incidence and outcome of hypernatremia after inpatient lactulose therapy for the treatment of acute hepatic encephalopathy: a retrospective analysis
• Haj M & Rockey DC. Evaluation of abnormal liver function tests in the hospital setting
• Haj M, et al. Evaluation of patients with pulmonary hypertension in the ED
• Haj M & Elmunzer BJ. Safety and efficacy of rectal indomethacin for post-ERCP pancreatitis in patients with cirrhosis
• Haj M & Elmunzer BJ. Pharmacological approaches to reducing post-ERCP pancreatitis
• Haj M & Elmunzer BJ. Outcomes after POEM for esophagogastric junction outflow obstruction (EGJOO)
• Haj M & Elmunzer BJ. Outcomes after endoscopic treatment of recalcitrant esophageal strictures
• Haj M & Steinberg D. Surgical aortic valve replacement vs transcatheter aortic valve replacement in cirrhotics